AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling. (2017)
Attributed to:
Precision Medicine Exeter Innovation Platform (PMEI Platform): Proof of Concept Funds
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.13688
PubMed Identifier: 27930802
Publication URI: http://europepmc.org/abstract/MED/27930802
Type: Journal Article/Review
Volume: 174
Parent Publication: British journal of pharmacology
Issue: 4
ISSN: 0007-1188